8-K

Company

Nautilus Biotechnology, Inc.

Filed

August 2, 2022

Period of Report

August 2, 2022

Accession Number

0001808805-22-000079

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →